June 30, 2025

Can Typos Change a Diagnosis?

Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.

Conexiant

June 27, 2025

Could Vertigo Be Signaling Something More?

Dizziness may be more than a balance issue—research links vestibular disorders to significantly increased mental health risks.

Conexiant

June 27, 2025

Does Erenumab Prevent Chronic Cluster Headaches?

Trial finds erenumab no more effective than placebo in preventing chronic cluster headache attacks.

Conexiant

June 26, 2025

MRI Accurately Distinguishes Menière’s From Migraine

A new prospective study found that hydrops MRI using cochlear and vestibular imaging markers can accurately differentiate Menière’s disease from vestibular migraine, offering a non-invasive diagnostic tool for clinicians dealing with overlapping symptoms.

Conexiant

June 24, 2025

Liraglutide Linked to Fewer Migraine Days

A small observational study found that liraglutide, a GLP-1 receptor agonist typically used to treat diabetes and support weight loss, significantly reduced migraine frequency in adults with a BMI of 30 or higher—independent of weight change.

Conexiant

June 11, 2025

Does Paracetamol Block Peripheral Pain?

A newly published study showed that a metabolite of paracetamol can directly block sodium channels in peripheral pain-sensing neurons, helping reduce pain without acting on the brain.

Conexiant

June 06, 2025

FDA Monthly Round-up: Key May Updates

May’s FDA approvals include the first at-home HPV test, a blood-based Alzheimer’s diagnostic, biosimilars, AI-enabled imaging tools, and novel therapies across cardiology, pulmonology, neurology, gastroenterology, and more.

Conexiant

June 04, 2025

Medical Oddities: Legumes Over Lipids?

From ticklish brains to bean-powered cholesterol drops, here’s what made the medical rounds weirdly wonderful this week.

Conexiant

April 28, 2025

One Third Report HPPD After Psychedelics

Delusional ideation was found to be reduced one month after psychedelic use, researchers reported in a prospective cohort of 654 participants.

Conexiant